You have 9 free searches left this month | for more free features.

Thoracic radiotherapy

Showing 1 - 25 of 8,295

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dual Energy Computed Tomography in Thoracic Radiotherapy

Completed
  • Lung Cancer
  • +2 more
  • Thoracic radiotherapy
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Nov 11, 2022

Small-cell Lung Cancer Trial in Shanghai (thoracic radiotherapy)

Recruiting
  • Small-cell Lung Cancer
  • thoracic radiotherapy
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Sep 21, 2022

NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

Recruiting
  • NSCLC, Stage III
  • Durvalumab Injection [Imfinzi]
  • +2 more
  • Aachen, Germany
  • +13 more
Nov 29, 2022

Cancer Trial in Los Angeles (Cardiac Aggressive Risk MitigAtion Plan)

Recruiting
  • Cancer
  • Cardiac Aggressive Risk MitigAtion Plan
  • Los Angeles, California
    Cancer Clinical Trials Office
Jan 10, 2023

SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)

Recruiting
  • SCLC,Extensive Stage
  • Thoracic radiotherapy
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 14, 2022

Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Sydney, New South Wales, Australia
  • +6 more
Mar 21, 2023

NSCLC Stage III Trial in Shanghai (standar thoracic RT dose, decreased thoracic RT dose)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • standar thoracic RT dose
  • decreased thoracic RT dose
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Sep 27, 2022

NSCLC Trial in Guangzhou (split-course radiotherapy, concurrent chemo)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • concurrent chemotherapy
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

NSCLC, Squamous Cell Carcinoma Trial in Wuhan (Nab-paclitaxel, Carboplatin, Thoracic radiation therapy)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Squamous Cell Carcinoma
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 26, 2022

Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

Recruiting
  • Small Cell Lung Cancer
  • Lung Cancer
  • Aarau, Switzerland
  • +13 more
Aug 12, 2022

Stage IV NSCLC Trial (Thoracic Three-dimensional Radiotherapy)

Not yet recruiting
  • Stage IV Non-small Cell Lung Cancer
  • Thoracic Three-dimensional Radiotherapy
  • (no location specified)
Dec 15, 2021

Small Cell Lung Cancer Extensive Stage, Thoracic Radiotherapy Trial in Linz, Heidelberg (Atezolizumab, thoracic radiotherapy

Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Thoracic Radiotherapy
  • Linz, Austria
  • +1 more
Aug 25, 2021

Lung Cancer, Small-Cell Lung Cancer Trial in Toronto (Talazoparib in Combination with Low Dose Radiotherapy (RT))

Recruiting
  • Lung Cancer
  • Small-Cell Lung Cancer
  • Talazoparib in Combination with Low Dose Radiotherapy (RT)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center, University Health Network
Feb 25, 2022

Sarcoma, Thoracic Cancer, Abdominal Cancer Trial in Saint Louis (Stereotactic body radiotherapy, Research blood draw)

Active, not recruiting
  • Sarcoma
  • +3 more
  • Stereotactic body radiotherapy
  • Research blood draw
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 17, 2022

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • (no location specified)
Jun 2, 2023

AI-assisted Radiotherapy Contouring Software for Thoracic Organs

Recruiting
  • Lung Cancer
  • +2 more
  • contouring of thoracic organs at risk
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital, Tianji
Mar 27, 2023

Small Cell Lung Carcinoma Trial in Denmark, Norway, Sweden (45 Gy in 30 fractions, 60 Gy in 40 fractions)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • 45 Gy in 30 fractions
  • 60 Gy in 40 fractions
  • København, Denmark
  • +21 more
Sep 16, 2022

Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

Not yet recruiting
  • Small Cell Lung Cancer Limited Stage
  • Prophylactic cranial irradiation
  • +2 more
  • (no location specified)
Dec 14, 2022

Evaluation of Early Signs of Myocardial Injury After Thoracic

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 6, 2023

Small-cell Lung Cancer Trial in Worldwide (Thoracic radiotherapy, Chemo-immunotherapy)

Recruiting
  • Small-cell Lung Cancer
  • København, Denmark
  • +18 more
Feb 3, 2022

NSCLC Trial in Tampa, Chapel Hill, Durham (Thoracic Radiotherapy, Platinum Based Chemotherapy, Ipilimumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Thoracic Radiotherapy
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 30, 2022

Radiotherapy; Complications, Cardiotoxicity, Cancer Trial in Santiago

Recruiting
  • Radiotherapy; Complications
  • +5 more
    • Santiago, Metropolitana, Chile
      Pontificia Universidad Catolica de Chile
    May 17, 2021

    Palliative Thoracic ImmunoRT

    Recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer
    • Radiation combined with immunotherapy
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Cancer Centre
    Oct 1, 2021

    Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

    Not yet recruiting
    • Chemotherapy
    • Radiation Therapy
    • Fuzhou, China
      Fujian Medical University Union Hospital
    Apr 6, 2023

    SBRT in Treatment of Thoracic Malignant Tumors at Different

    Recruiting
    • Radiotherapy
    • +2 more
    • stereotactic body radiation therapy
    • Beijing, Beijing, China
      Peking University Third Hospital
    May 31, 2022